These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
101 related items for PubMed ID: 8575520
1. Evidence for a 5-HT1D receptor-mediated hypothermic effect of the alpha 1-adrenoceptor agonist, SDZ NVI-085, in guinea-pigs. Kalkman HO, Neumann V. Eur J Pharmacol; 1995 Oct 24; 285(3):313-5. PubMed ID: 8575520 [Abstract] [Full Text] [Related]
2. The adrenoceptor agonist, SDZ NVI 085, discriminates between alpha 1A- and alpha 1B-adrenoceptor subtypes in vas deferens, kidney and aorta of the rat. Eltze M, Boer R. Eur J Pharmacol; 1992 Dec 02; 224(2-3):125-36. PubMed ID: 1361446 [Abstract] [Full Text] [Related]
3. SDZ NVI 085, an alpha 1A-adrenoceptor agonist with 5-HT2A receptor antagonist properties. Lachnit WG, Ford AP, Clarke DE. Eur J Pharmacol; 1996 Feb 15; 297(1-2):83-6. PubMed ID: 8851170 [Abstract] [Full Text] [Related]
4. Characterization of alpha1-adrenoceptor subtypes in facilitation of rat spinal motoneuron activity. Wada T, Hasegawa Y, Ono H. Eur J Pharmacol; 1997 Dec 04; 340(1):45-52. PubMed ID: 9527505 [Abstract] [Full Text] [Related]
6. The alpha 1-adrenoceptor agonist, SDZ NVI-085, behaves as a potent, competitive antagonist of 5-hydroxytryptamine-induced contraction of rat aorta. Van der Graaf PH, Apaydin S, Saxena PR. Eur J Pharmacol; 1995 Dec 20; 287(3):309-12. PubMed ID: 8991806 [Abstract] [Full Text] [Related]
7. Alpha 1-adrenoceptor subtype(s) mediating noradrenaline-induced contractions of the guinea-pig aorta. Oriowo MA. Fundam Clin Pharmacol; 1994 Dec 20; 8(3):214-9. PubMed ID: 7927117 [Abstract] [Full Text] [Related]
8. Is SDZ NVI-085 an alpha 1-adrenoceptor subtype-selective agonist? Büscher R, Insel PA, Michel MC. Life Sci; 1994 Dec 20; 54(14):999-1007. PubMed ID: 7908116 [Abstract] [Full Text] [Related]
9. Characterization of the alpha 1-adrenoceptor subtype mediating contraction of guinea-pig spleen. Eltze M. Eur J Pharmacol; 1994 Aug 01; 260(2-3):211-20. PubMed ID: 7988645 [Abstract] [Full Text] [Related]
10. Head and whole-body jerking in guinea pigs are differentially modulated by 5-HT1A, 5-HT1B/1D and 5-HT2A receptor antagonists. Nielsen CK. Eur J Pharmacol; 1998 Nov 20; 361(2-3):185-90. PubMed ID: 9865507 [Abstract] [Full Text] [Related]
11. Differences in the effects of ketanserin and GR127935 on 5-HT-receptor mediated responses in rabbit saphenous vein and guinea-pig jugular vein. Razzaque Z, Longmore J, Hill RG. Eur J Pharmacol; 1995 Sep 05; 283(1-3):199-206. PubMed ID: 7498311 [Abstract] [Full Text] [Related]
12. Functional evidence for an alpha 1B-adrenoceptor mediating contraction of the mouse spleen. Eltze M. Eur J Pharmacol; 1996 Sep 12; 311(2-3):187-98. PubMed ID: 8891599 [Abstract] [Full Text] [Related]
13. WAY-100635 and GR127935: effects on 5-hydroxytryptamine-containing neurones. Craven R, Grahame-Smith D, Newberry N. Eur J Pharmacol; 1994 Dec 12; 271(1):R1-3. PubMed ID: 7698189 [Abstract] [Full Text] [Related]
15. GR127935 acts as a partial agonist at recombinant human 5-HT1D alpha and 5-HT1D beta receptors. Watson JM, Burton MJ, Price GW, Jones BJ, Middlemiss DN. Eur J Pharmacol; 1996 Oct 31; 314(3):365-72. PubMed ID: 8957260 [Abstract] [Full Text] [Related]
16. The activity of 5-HT1D receptor ligands at cloned human 5-HT1D alpha and 5-HT1D beta receptors. Walsh DM, Beattie DT, Connor HE. Eur J Pharmacol; 1995 Dec 04; 287(1):79-84. PubMed ID: 8666030 [Abstract] [Full Text] [Related]
17. Canine external carotid vasoconstriction to methysergide, ergotamine and dihydroergotamine: role of 5-HT1B/1D receptors and alpha2-adrenoceptors. Villalón CM, De Vries P, Rabelo G, Centurión D, Sánchez-López A, Saxena P. Br J Pharmacol; 1999 Feb 04; 126(3):585-94. PubMed ID: 10188968 [Abstract] [Full Text] [Related]
18. 5-HT1A receptors and the tail-flick response. VI. Intrinsic alpha 1A-adrenoceptor antagonist properties can mask the actions of 5-HT1A receptor agonists in the spontaneous tail-flick paradigm. Millan MJ, Rivet JM, Gobert A, Canton H, Veiga S, Bervoets K. J Pharmacol Exp Ther; 1994 Apr 04; 269(1):121-31. PubMed ID: 7909555 [Abstract] [Full Text] [Related]